Toru Kimura
6 Papers
25 Citations
Toru Kimura is an academic researcher. The author has contributed to research in topics: Ureter & Pyeloplasty. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Laparoscopic pyeloplasty using endoscopic GIA stapler for ureteropelvic junction obstruction.
Hidemori Araki,Yoshinari Ono,Ryohei Hattori,Momokazu Goto,Tokunori Yamamoto,Toru Kimura,Shinichi Ohshima +6 more
TL;DR: Laroscopic dismembered pyeloplasty including the Endo-GIA stapler technique is an efficient and safe procedure that provides excellent results for extrinsic or complicated UPJ stenosis.
14
pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
Tomoyasu Sano,Masashi Kato,Naoto Sassa,Ryo Sadachi,Akihiro Hirakawa,Osamu Kamihira,Tsuyoki Hirabayashi,Toshinori Nishikimi,Satoshi Katsuno,Toru Kimura,Ryohei Hattori,Momokazu Gotoh,Toyonori Tsuzuki +12 more
TL;DR: In this paper, the authors compared the prognosis of pT3 urothelial carcinoma of the renal pelvis (UCRP) with that of UCU (UCU) using Fine and Gray's model to predict recurrence-free survival and cancer-specific survival.
6
Identification of the narrow lumen of the ureter using a Fogarty catheter during laparoscopic pyeloplasty.
Yoshikazu Tsuji,Tsuneo Kinukawa,Akitaka Suzuki,Shohei Ishida,Takashi Fujita,Tomonori Komatsu,Toru Kimura,Kuniaki Tanaka,Ryohei Hattori +8 more
TL;DR: A new method, the Fogarty test, is developed and named, to identify the narrow sites of the ureter using a Fogarty catheter, and is useful for sufficient spatulation of intrinsic Ureteral stricture, especially in patients where multiple narrow sites exist.
3
A case of early graft loss due to hyperacute rejection after ABO-incompatible renal transplantation
Katsunori Horie,Yasuko Kanou,Motoyoshi Sato,Mikito Tsuyuki,Shohei Ishida,Takeo Shimoji,Takashi Fujita,Toru Kimura,Masashi Kato,Yoshikazu Tsuji,Tsuneo Kinukawa +10 more
TL;DR: There is no clear standard for preoperative antibody values and it is difficult to predict prognosis preoperatively with the recent use of strong immunosuppressives, but it is believed that the antibody titer should be reduced as much as possible prior to transplantation.
2
The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study
Yushi Naito,Masashi Kato,Hideji Kawanishi,Yuri Yuguchi,Takuma Yuba,Tomohiro Ishikawa,Kyosuke Hattori,Akiyuki Yamamoto,Tomoyasu Sano,Yoshihisa Matsukawa,Toru Kimura,Toshinori Nishikimi,Ryohei Hattori,Toyonori Tsuzuki,Momokazu Gotoh +14 more
TL;DR: This work compared the effect of ART‐to‐ART (AA) sequential therapy after castration resistance with that of docetaxel (DTX)‐combined sequential therapy (ART to DTX or DTX to ART) in patients with CRPC.
1